Posts Tagged ‘Focus’

Kearney wellness fair to focus on diabetes awareness
World-Herald News Service KEARNEY — Good Samaritan Hospital plans a free Diabetes Health and Wellness Fair from 9 a.m. to 1 p.m. on Saturday, Oct. 30, at the Holiday Inn Convention Center.

Read more on Grand Island Independent

Visit robbybarbaro.org and search for the title of this video for more information.

(AFX UK Focus) 2010-06-28 19:22 Q+A-Does Avandia damage the heart? Questions remain
WASHINGTON, June 28 (Reuters) – Two studies released on Monday show GlaxoSmithKline Plc diabetes pill Avandia may damage the heart, adding to pressure on U.S. regulators deciding whether the drug should stay on the market. Here are some questions and answers about the issues surrounding Avandia, which is still a blockbuster drug, with $1.2 billion in sales in 2009.

(AFX UK Focus) 2010-06-26 16:55 Roche says diabetes drug studies show good results
ZURICH, June 26 (Reuters) – Swiss drugmaker Roche’s experimental diabetes drug taspoglutide showed good results in a series of late-stage studies, the group said on Saturday, after the drug suffered a severe setback just recently. Roche launched a risk mitigation programme for the drug developed under license from French group Ipsen after hypersensitivity problems were seen in some patients …

Diabetes experts to focus full attention on condition at Orlando meeting
Diabetes affects 24 million children and adults in the United States and costs the nation $174 billion every year. Scientists and doctors around the country are studying every aspect of the disease — and 15,000 of them will meet in Orlando this weekend for the American Diabetes Association’s annual scientific meeting.

(AFX UK Focus) 2010-06-18 10:25 UPDATE 3-Roche, Ipsen drug faces at least 12-18 month delay
By Ben Hirschler

(AFX UK Focus) 2010-06-15 18:41 U.S. FDA advisory meetings through Dec 15
THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL ITEMS EDT/GMT until Nov. 7, when EST/GMT resumes. For more information on the FDA’s Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm